Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > RS

<< Previous

Bullboard Posts

Next >>

Comment by Trickson Nov 30, 2020 4:32pm

185 Views

Post# 32003006

RE:RE:RS

Unfortunately people on this board think because the science is good that it'll translate to the stock price rising which hasn't been the case. What has ATE done since the phase 2 results? Sell shares, dilute shares and now a reverse split all the while stock has taken at tumble from .89 so I'm not sure why people are looking at this RS with such optimism and confidence.

Pandora wrote:

crow27 wrote: If you have the goods a RS will not hurt you. It actually helps in that your share count drops dramatically. Now if you have nothing going for you and you are just trying to reduce your float then your stock will continue to slide after the split.
ATE is not in that situation as the good news is about to be announced and that will drive the stock higher. Remember a .10 cent gain or drop after the split is like us gaining or losing .01 cent before the split.
Nothing to fear about the RS, they are doing it from a situation of strength not weekness.

Yes that's right. Check out V.BCT. It went 1 for 300 last January. 4 cents to $12. Briefly ran over $20 in the first month and is now at $4.79 and still waiting to get the Nasdaq nod. Were they prepared for the move? The CEO swore that they were and was totally confident that the action was right and the timing was right. The 100 shares that I was left with, out of the 30,000 I originally had, I bailed out at $19. $1900 left out of the original $9000. Just love the RS.

Then there was also SYTA -- it was 1 for 145. Just has to go from $6 U.S. to $60 U.S. for me to get my original back. I could rattle off another 6 but won't bore you.

But I'll take your word for it -- this one will be different!